Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07529366 · ClinicalTrials.gov registry record
Pharmacist-Led Continuous Glucose Monitoring for Prediabetes
A clinical trial, sponsored by University of South Florida.
- Recruiting
- Registry status
- 40
- Enrollment target
NCT07529366 is a clinical trial that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 40 participants.
The verdict
NCT07529366 is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine if a pharmacist-led program involving continuous glucose monitoring (CGM) improves glucose control and health behavior in people with prediabetes. The main questions it aims to answer are: 1. Determine impact of pharmacist-led CGM on glycemic control in people with prediabetes. Researchers will compare change in hemoglobin A1c at 12 weeks with pharmacist-led CGM versus a historical cohort of subjects with prediabetes receiving no CGM. The investigators will also assess change in CGM-derived glycemic metrics from baseline to end of the CGM wear period in the intervention group. 2. Evaluate impact of pharmacist-led CGM on health behavior change in people with prediabetes in the intervention group. Participants will be asked to complete the Summary of Diabetes Self-Care Activities Measure (SDSCA) and 36-Item Short Form Health Survey (SF-36) at baseline, at the end of week 4, and at the end of the study so that researchers can measure the effects in the intervention group on health behavior change.
Interventions
- DEVICE Dexcom Stelo CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07529366
The ClinicalTrials.gov registry entry for NCT07529366 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Stelo CGM is the first listed.
NCT07529366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07529366 about?
NCT07529366 is a clinical study titled "Pharmacist-Led Continuous Glucose Monitoring for Prediabetes". The goal of this observational study is to determine if a pharmacist-led program involving continuous glucose monitoring (CGM) improves glucose control and health behavior in people with prediabetes. The main questions it aims to answer are: 1. Determine impact of pharmacist-led CGM on glycemic con...
What is the current status of trial NCT07529366?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2026-06-01. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT07529366?
The interventions under investigation include: Dexcom Stelo CGM (DEVICE).
Who is sponsoring clinical trial NCT07529366?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.